Beximco Pharma

05/11/2025

1st Time in Bangladesh from Beximco Pharma, Rosutin EZ, a preparation of Rosuvastatin & Ezetimibe for powerful LDL-C reduction and proven cardioprotection.

Unmatched Power. Unparalleled Protection.

05/11/2025

1st Time in Bangladesh from Beximco Pharma, Rosutin EZ, a preparation of Rosuvastatin & Ezetimibe for powerful LDL-C reduction and proven cardioprotection.

05/11/2025

New from Beximco Pharma, the Makers of Bangladesh’s most trusted Paracetamol brand, for the FIRST TIME in Bangladesh, N-MAX – fixed dose combination of Paracetamol and Ibuprofen for multimodal management of acute moderate pain.

05/11/2025

New from Beximco Pharma, the Makers of Bangladesh’s most trusted Paracetamol brand, for the FIRST TIME in Bangladesh, N-MAX – fixed dose combination of Paracetamol and Ibuprofen for multimodal management of acute moderate pain.

04/11/2025

Beximco Pharma was featured in today’s Prothom Alo

30/10/2025

On 29 October, the Bangladesh Ambassador to Germany, H.E. Muhammad Zulqar Nain, visited Beximco Pharma stand at CPhI, Frankfurt. He praised about Beximco Pharma’s significant role in providing access to world class medicines across all the continents. He was also present during the signing of agreement with one of our overseas partners.

29/10/2025

https://www.tbsnews.net/supplement/beximco-pharma-building-global-legacy-bangladesh-1271911

From a homegrown manufacturer to a trusted global brand, Beximco Pharma embodies Bangladesh’s growing strength in healthcare and its mission to make world-class medicines affordable for all

29/10/2025

স্ট্রোকের সময় দ্রুত চিকিৎসা পেলে বেঁচে যাওয়ার সম্ভাবনা বেড়ে যায় বহু গুণ।
উচ্চ রক্তচাপ, ডায়াবেটিস, ধূমপান, উচ্চ কোলেস্টেরল — এগুলোর নিয়ন্ত্রণই স্ট্রোকের ঝুঁকি কমায়।

তাই এইসব রোগকে নিমন্ত্রণ না জানিয়ে আজ থেকেই নিয়ন্ত্রণ শুরু করুন।
সময় মতো ডাক্তারের পরামর্শ নিন, ওষুধ খান, সুস্থ থাকুন।

28/10/2025

Beximco Pharma team attending CPhI Global 2025 at Frankfurt, Germany during 28-30 October

25/10/2025

সিস্টিক ফাইব্রোসিসে আক্রান্ত শিশুদের চিকিৎসায় সাশ্রয়ী ওষুধ তৈরি করলো বেক্সিমকো ফার্মা। প্রতিষ্ঠানটি ২৩ অক্টো.....

25/10/2025

In a historic development for cystic fibrosis (CF) patients worldwide, Beximco Pharmaceuticals Ltd has introduced Triko, a low-cost generic version of Trikafta, the breakthrough triple combination therapy developed by US-based Vertex Pharmaceuticals. The announcement was made on 23 October at the No...

25/10/2025

Beximco Pharma’s commendable role in providing access to lifesaving treatment for cystic fibrosis is being applauded in global media

Our views on what governments and the international community can do to fight this pandemic and prepare for the next one.